DIETER KURT HOSSFELD

机构：Universität Hamburg, University Medical Center Hamburg-Eppendorf

发表论文 314 篇 · 总被引 9640 次 · h-index 44

代表论文

• Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017 · Leukemia · 被引 342)
• Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia (2011 · Journal of Clinical Oncology · 被引 324)
• Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV (2013 · Journal of Clinical Oncology · 被引 303)
• High-risk additional chromosomal abnormalities at low blast counts herald death by CML (2020 · Leukemia · 被引 94)
• Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV (2016 · Leukemia · 被引 88)
• Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV (2013 · Annals of Hematology · 被引 81)